NDC11 52652400101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 52652-4001-01 | 52652-4001 |
| 52652-4001-1 | 52652-4001 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Epaned | ENALAPRIL MALEATE | Azurity Pharmaceuticals, Inc. | e6dbda02-779e-420c-893d-d0fea09432be | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 52652-4001-1 52652-4001 52652400101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.